Reshaping the Treatment Landscape for Recurrent/Metastatic Nasopharyngeal Carcinoma - OncLive
5/26/2022 12:00:00 AM3 years 9 months ago
by Kristi Rosa, Brittany Lovely
by Kristi Rosa, Brittany Lovely
In the context of checkpoint blockade in nasopharyngeal carcinoma, the results of the phase 3 RATIONALE-309 trial support earlier findings of the role immunotherapy may play for patients in the first line.
In the context of checkpoint blockade in nasopharyngeal carcinoma, the results of the phase 3 RATIONALE-309 trial (NCT03924986) support earlier findings of the role immunotherapy may play for patient… [+7391 chars]
full article...